MiRNAs: Potential As Biomarkers and Therapeutic Targets for Cancer

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2023 Jul 29

PMID 37510280

Authors

Atonu Chakrabortty

Daniel J Patton

Bruce F Smith

Payal Agarwal

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are single-stranded, non-coding RNA molecules that regulate gene expression post-transcriptionally by binding to messenger RNAs. miRNAs are important regulators of gene expression, and their dysregulation is implicated in many human and canine diseases. Most cancers tested to date have been shown to express altered miRNA levels, which indicates their potential importance in the oncogenic process. Based on this evidence, numerous miRNAs have been suggested as potential cancer biomarkers for both diagnosis and prognosis. miRNA-based therapies have also been tested in different cancers and have provided measurable clinical benefits to patients. In addition, understanding miRNA biogenesis and regulatory mechanisms in cancer can provide important knowledge about resistance to chemotherapies, leading to more personalized cancer treatment. In this review, we comprehensively summarized the importance of miRNA in human and canine cancer research. We discussed the current state of development and potential for the miRNA as both a diagnostic marker and a therapeutic target.

Citing Articles

Identification of novel diagnostic and prognostic microRNAs in sarcoma on TCGA dataset: bioinformatics and machine learning approach.

Rahmati R, Zarimeidani F, Ahmadi F, Yousefi-Koma H, Mohammadnia A, Hajimoradi M Sci Rep. 2025; 15(1):7521.

PMID: 40032929 PMC: 11876432. DOI: 10.1038/s41598-025-91007-x.

Peiminine Enhances Doxorubicin Cytotoxicity and Downregulates hsa-miR-106a-5p and hsa -miR-181a-5p in Human Gastric Adenocarcinoma Cells.

Hedayati S, Soltanzadeh H, Esmaeili Gouvarchin Ghaleh H, Bonab Z, Alvanegh A Adv Biomed Res. 2025; 13:121.

PMID: 40007732 PMC: 11850945. DOI: 10.4103/abr.abr_535_23.

miRNA Signatures as Predictors of Therapy Response in Castration-Resistant Prostate Cancer: Insights from Clinical Liquid Biopsies and 3D Culture Models.

Puente-Rivera J, Nunez-Olvera S, Fernandez-Sanchez V, Cureno-Diaz M, Gomez-Zamora E, Plascencia-Nieto E Genes (Basel). 2025; 16(2).

PMID: 40004509 PMC: 11855684. DOI: 10.3390/genes16020180.

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment.

Gong L, Zou C, Zhang H, Yang F, Qi G, Ma Z Genes (Basel). 2025; 16(2).

PMID: 40004471 PMC: 11855738. DOI: 10.3390/genes16020140.

The Application of MicroRNAs in Traumatic Brain Injury: Mechanism Elucidation and Clinical Translation.

Wang H, Fan X, Zhang Y, Ma N, Li L, Lu Q Mol Neurobiol. 2025; .

PMID: 39946001 DOI: 10.1007/s12035-025-04737-4.

References

Macfarlane L, Murphy P . MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2011; 11(7):537-61. PMC: 3048316. DOI: 10.2174/138920210793175895. View

Ma T, Yang L, Zhang J . MiRNA‑542‑3p downregulation promotes trastuzumab resistance in breast cancer cells via AKT activation. Oncol Rep. 2015; 33(3):1215-20. DOI: 10.3892/or.2015.3713. View

Negrini M, Calin G . Breast cancer metastasis: a microRNA story. Breast Cancer Res. 2008; 10(2):203. PMC: 2397516. DOI: 10.1186/bcr1867. View

Zhu Y, Liang Z, Li S, Xu X, Wang X, Wu J . c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling. Cell Death Dis. 2016; 7:e2088. PMC: 4849142. DOI: 10.1038/cddis.2015.274. View

Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H . Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am J Transl Res. 2014; 6(4):391-401. PMC: 4113501. View

Baradaran B, Shahbazi R, Khordadmehr M . Dysregulation of key microRNAs in pancreatic cancer development. Biomed Pharmacother. 2018; 109:1008-1015. DOI: 10.1016/j.biopha.2018.10.177. View

Nagesh P, Chowdhury P, Hatami E, Boya V, Kashyap V, Khan S . miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy. Cancers (Basel). 2018; 10(9). PMC: 6162422. DOI: 10.3390/cancers10090289. View

Niu J, Xue A, Chi Y, Xue J, Wang W, Zhao Z . Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer. Oncogene. 2015; 35(10):1302-1313. PMC: 4666837. DOI: 10.1038/onc.2015.189. View

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

10.

Teplyuk N, Uhlmann E, Gabriely G, Volfovsky N, Wang Y, Teng J . Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic. EMBO Mol Med. 2016; 8(3):268-87. PMC: 4772951. DOI: 10.15252/emmm.201505495. View

11.

Mogilyansky E, Rigoutsos I . The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013; 20(12):1603-14. PMC: 3824591. DOI: 10.1038/cdd.2013.125. View

12.

Li D, Zhu G, Di H, Li H, Liu X, Zhao M . Associations between genetic variants located in mature microRNAs and risk of lung cancer. Oncotarget. 2016; 7(27):41715-41724. PMC: 5173090. DOI: 10.18632/oncotarget.9566. View

13.

Yu S, Chen H, Chang G, Chen C, Chen H, Singh S . MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008; 13(1):48-57. DOI: 10.1016/j.ccr.2007.12.008. View

14.

Fogli S, Polini B, Carpi S, Pardini B, Naccarati A, Dubbini N . Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. Tumour Biol. 2017; 39(5):1010428317701646. DOI: 10.1177/1010428317701646. View

15.

Xie Z, Chen G, Zhang X, Li D, Huang J, Yang C . Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One. 2013; 8(4):e57502. PMC: 3613402. DOI: 10.1371/journal.pone.0057502. View

16.

Heishima K, Ichikawa Y, Yoshida K, Iwasaki R, Sakai H, Nakagawa T . Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease. Sci Rep. 2017; 7(1):2301. PMC: 5442106. DOI: 10.1038/s41598-017-02607-1. View

17.

Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P . Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther. 2013; 21(5):986-94. PMC: 3666633. DOI: 10.1038/mt.2013.35. View

18.

Boggs R, Wright Z, Stickney M, Porter W, Murphy K . MicroRNA expression in canine mammary cancer. Mamm Genome. 2008; 19(7-8):561-9. DOI: 10.1007/s00335-008-9128-7. View

19.

Zhu H, Han C, Wu T . MiR-17-92 cluster promotes hepatocarcinogenesis. Carcinogenesis. 2015; 36(10):1213-22. PMC: 4794620. DOI: 10.1093/carcin/bgv112. View

20.

Tong S, Liu J, Wang X, Qu L . microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. Exp Ther Med. 2014; 8(4):1296-1300. PMC: 4151665. DOI: 10.3892/etm.2014.1846. View